15 May 2020
For the majority of CFO’s in the Covid-19 climate, the spotlight is upon them. The pandemic presents shrinking balance sheets, growing risks, and challenges to the supply chain, meanwhile with the increasing pressure of being judged by how they act during this tumultuous time towards their employees and shareholders.
29 April 2020
The Impact of Digital within Finance
Over the last few years, we’ve seen organisations improving the agility of how their core business functions and workforce operates, leveraging their talent and access to technology to create teams that perform to their best.
18 March 2020
Biosimilar drugs deemed to be the ‘real deal’ in today’s Biopharmaceutical landscape
In the current financial climate, with National Health Services across Western countries under increasing pressure to ‘do more with less’, biosimilar drugs are starting to attract significant attention and are likely to reshape the pharmaceutical industry as we know it.
11 March 2020
Industry Executives - Q&A
Recently Dan Nathan, Managing Partner at Euromedica, spoke with Olivier Charmeil, Executive Committee member and EVP, General Medicines at Sanofi, as he moves into a new internal position and to share his insights on leadership within a transformational industry.
Get in touch to learn how we can add value to your business or career.